{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T04:32:19Z","timestamp":1789187539982,"version":"build-2803163510"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,7,20]],"date-time":"2014-07-20T00:00:00Z","timestamp":1405814400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2334-14-404","type":"journal-article","created":{"date-parts":[[2014,7,20]],"date-time":"2014-07-20T09:00:42Z","timestamp":1405846842000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Case report: failure under azithromycin treatment in a case of bacteremia due to Salmonella enterica Paratyphi A"],"prefix":"10.1186","volume":"14","author":[{"given":"Tetsuro","family":"Kobayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayoko","family":"Hayakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Momoko","family":"Mawatari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhisa","family":"Mezaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nozomi","family":"Takeshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Kutsuna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Fujiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuzo","family":"Kanagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Ohmagari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatomo","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,7,20]]},"reference":[{"key":"3711_CR1","first-page":"346","volume":"82","author":"JA Crump","year":"2004","unstructured":"Crump JA, Luby SP, Mintz ED: The global burden of typhoid fever. Bull World Health Organ. 2004, 82: 346-353.","journal-title":"Bull World Health Organ"},{"key":"3711_CR2","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1093\/cid\/cis600","volume":"55","author":"RM Humphries","year":"2012","unstructured":"Humphries RM, Fang FC, Aarestrup FM, Hindler JA: In vitro susceptibility testing of fluoroquinolone activity against Salmonella: recent changes to CLSI standards. Clin Infect Dis. 2012, 55: 1107-1113.","journal-title":"Clin Infect Dis"},{"key":"3711_CR3","doi-asserted-by":"publisher","first-page":"456","DOI":"10.7326\/0003-4819-158-6-201303190-00005","volume":"158","author":"K Leder","year":"2013","unstructured":"Leder K, Torresi J, Libman MD, Cramer JP, Castelli F, Schlagenhauf P, Wilder-Smith A, Wilson ME, Keystone JS, Schwartz E, Barnett ED, von Sonnenburg F, Brownstein JS, Cheng AC, Sotir MJ, Esposito DH, Freedman DO, GeoSentinel Surveillance Network: GeoSentinel surveillance of illness in returned travelers, 2007\u20132011. Ann Intern Med. 2013, 158: 456-468.","journal-title":"Ann Intern Med"},{"key":"3711_CR4","doi-asserted-by":"publisher","first-page":"860","DOI":"10.3201\/eid1405.071184","volume":"14","author":"EJ Threlfall","year":"2008","unstructured":"Threlfall EJ, de Pinna E, Day M, Lawrence J, Jones J: Alternatives to ciprofloxacin use for enteric fever, United Kingdom. Emerg Infect Dis. 2008, 14: 860-861.","journal-title":"Emerg Infect Dis"},{"key":"3711_CR5","volume-title":"M100-23 Performance Standards for Antimicrobial Susceptibility Testing","author":"Clinical and Laboratory Standards Institute","year":"2013","unstructured":"Clinical and Laboratory Standards Institute: M100-23 Performance Standards for Antimicrobial Susceptibility Testing. 2013, Wayne, PA, , Twenty-Third Informational Supplement"},{"key":"3711_CR6","volume-title":"Breakpoint Tables for Interpretation of MICs and Zone Diameters Version 3.1","author":"The European Committee on Antimicrobial Susceptibility Testing (EUCAST)","year":"2013","unstructured":"The European Committee on Antimicrobial Susceptibility Testing (EUCAST): Breakpoint Tables for Interpretation of MICs and Zone Diameters Version 3.1. 2013, Available at: [\n                    http:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Breakpoint_tables\/Breakpoint_table_v_3.1.pdf\n                    \n                  ]. Accessed February 12, 2014"},{"key":"3711_CR7","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/jac\/44.2.243","volume":"44","author":"T Butler","year":"1999","unstructured":"Butler T, Sridhar CB, Daga MK, Pathak K, Pandit RB, Khakhria R, Potkar CN, Zelasky MT, Johnson RB: Treatment of typhoid fever with azithromycin versus chloramphenicol in a randomized multicentre trial in India. J Antimicrob Chemother. 1999, 44: 243-250.","journal-title":"J Antimicrob Chemother"},{"key":"3711_CR8","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1128\/AAC.00447-06","volume":"51","author":"CM Parry","year":"2007","unstructured":"Parry CM, Ho VA, le Phuong T, Bay PV, Lanh MN, le Tung T, Tham NT, Wain J, Hien TT, Farrar JJ: Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever. Antimicrob Agents Chemother. 2007, 51: 819-825.","journal-title":"Antimicrob Agents Chemother"},{"key":"3711_CR9","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1128\/AAC.43.6.1441","volume":"43","author":"NI Girgis","year":"1999","unstructured":"Girgis NI, Butler T, Frenck RW, Sultan Y, Brown FM, Tribble D, Khakhria R: Azithromycin versus ciprofloxacin for treatment of uncomplicated typhoid fever in a randomized trial in Egypt that included patients with multidrug resistance. Antimicrob Agents Chemother. 1999, 43: 1441-1444.","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"3711_CR10","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1128\/AAC.44.7.1855-1859.2000","volume":"44","author":"NT Chinh","year":"2000","unstructured":"Chinh NT, Parry CM, Ly NT, Ha HD, Thong MX, Diep TS, Wain J, White NJ, Farrar JJ: A randomized controlled comparison of azithromycin and ofloxacin for treatment of multidrug-resistant or nalidixic acid-resistant enteric fever. Antimicrob Agents Chemother. 2000, 44 (7): 1855-1859.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"3711_CR11","doi-asserted-by":"publisher","first-page":"e2188","DOI":"10.1371\/journal.pone.0002188","volume":"3","author":"C Dolecek","year":"2008","unstructured":"Dolecek C, Tran TP, Nguyen NR, Le TP, Ha V, Phung QT, Doan CD, Nguyen TB, Duong TL, Luong BH, Nguyen TB, Nguyen TA, Pham ND, Mai NL, Phan VB, Vo AH, Nguyen VM, Tran TT, Tran TC, Schultsz C, Dunstan SJ, Stepniewska K, Campbell JI, To SD, Basnyat B, Nguyen VV, Nguyen VS, Nguyen TC, Tran TH, Farrar J: A multi-center randomised controlled trial of gatifloxacin versus azithromycin for the treatment of uncomplicated typhoid fever in children and adults in Vietnam. PLoS One. 2008, 3 (5): e2188-","journal-title":"PLoS One"},{"key":"3711_CR12","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/S0140-6736(05)67181-4","volume":"366","author":"MK Bhan","year":"2005","unstructured":"Bhan MK, Bahl R, Bhatnagar S: Typhoid and paratyphoid fever. Lancet. 2005, 366: 749-762.","journal-title":"Lancet"},{"key":"3711_CR13","first-page":"1277","volume-title":"Enteric (Typhoid) Fever. Volume 2","author":"DL Longo","year":"2011","unstructured":"Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J: Harrison\u2019s principles of internal medicine. Enteric (Typhoid) Fever. Volume 2. 2011, New York: McGraw Hill, 1277-18","edition":"18"},{"key":"3711_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004530.pub4","volume-title":"Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever)","author":"EE Effa","year":"2011","unstructured":"Effa EE, Lassi ZS, Critchley JA, Garner P, Sinclair D, Olliaro PL, Bhutta ZA: Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever). Cochrane Database Syst Rev. 2011, doi:10.1002\/14651858.CD004530.pub4, 10"},{"key":"3711_CR15","doi-asserted-by":"publisher","first-page":"4655","DOI":"10.1128\/JCM.00648-10","volume":"48","author":"A Molloy","year":"2010","unstructured":"Molloy A, Nair S, Cooke FJ, Wain J, Farrington M, Lehner PJ, Torok ME: First report of Salmonella enterica serotype paratyphi A azithromycin resistance leading to treatment failure. J Clin Microbiol. 2010, 48: 4655-4657.","journal-title":"J Clin Microbiol"},{"issue":"6","key":"3711_CR16","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1179\/2047773212Y.0000000010","volume":"106","author":"S Fernando","year":"2012","unstructured":"Fernando S, Molland JG, Gottlieb T: Failure of oral antibiotic therapy, including azithromycin, in the treatment of a recurrent breast abscess caused by Salmonella enterica serotype Paratyphi A. Pathog Glob Health. 2012, 106 (6): 366-369.","journal-title":"Pathog Glob Health"},{"key":"3711_CR17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1093\/jac\/37.suppl_C.37","volume":"37","author":"G Foulds","year":"1996","unstructured":"Foulds G, Luke DR, Teng R, Willavize SA, Friedman H, Curatolo WJ: The absence of an effect of food on the bioavailability of azithromycin administered as tablets, sachet or suspension. J Antimicrob Chemother. 1996, 37: 37-44.","journal-title":"J Antimicrob Chemother"},{"key":"3711_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jac\/31.suppl_E.1","volume":"31","author":"G Panteix","year":"1993","unstructured":"Panteix G, Guillaumond B, Harf R, Desbos A, Sapin V, Leclercq M, Perrin-Fayolle M: In-vitro concentration of azithromycin in human phagocytic cells. J Antimicrob Chemother. 1993, 31: 1-4.","journal-title":"J Antimicrob Chemother"},{"key":"3711_CR19","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1099\/jmm.0.47353-0","volume":"56","author":"MR Capoor","year":"2007","unstructured":"Capoor MR, Rawat D, Nair D, Hasan AS, Deb M, Aggarwal P, Pillai P: In vitro activity of azithromycin, newer quinolones and cephalosporins in ciprofloxacin-resistant Salmonella causing enteric fever. J Med Microbiol. 2007, 56: 1490-1494.","journal-title":"J Med Microbiol"},{"issue":"4","key":"3711_CR20","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3201\/eid2004.131536","volume":"20","author":"RJ Hassing","year":"2014","unstructured":"Hassing RJ, Goessens WH, van Pelt W, Mevius DJ, Stricker BH, Molhoek N, Verbon A, van Genderen PJ: Salmonella subtypes with increased MICs for azithromycin in travelers returned to The Netherlands. Emerg Infect Dis. 2014, 20 (4): 705-708.","journal-title":"Emerg Infect Dis"},{"issue":"10","key":"3711_CR21","first-page":"949","volume":"12","author":"MD Kraus","year":"1999","unstructured":"Kraus MD, Amatya B, Kimula Y: Histopathology of typhoid enteritis: morphologic and immunophenotypic findings. Mod Pathol. 1999, 12 (10): 949-955.","journal-title":"Mod Pathol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-404.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-14-404\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-404","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-404.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T05:31:00Z","timestamp":1548221460000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-14-404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,20]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["3711"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-14-404","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,20]]},"assertion":[{"value":"18 March 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"404"}}